Solventum Corporation

Solventum Corporation

SOLVยทNYSE

$78.36

+2.5%
HealthcareMedical - Care Facilities

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

At a Glance

Live Snapshot
Market Cap$13.57B
EPS8.9400
P/E Ratio8.77
Earnings Date08/06/2026
3Y+5.0%
5Y+2.0%
10Y+2.0%
3Y+399.0%
5Y+359.0%
10Y+359.0%
3Y-57.0%
5Y-58.0%
10Y-58.0%
solv

Solventum Corporation Funding & Solvency Profile

SOLV ยท NYSE
Cash & Cash Equivalents878.00M
Net Receivables1.03B
Inventory1.07B
Other Current Assets881.00M
Total Current Assets4 B
Property, Plant & Equipment1.33B
Goodwill & Intangible Assets8.30B
Long-Term Investments0.00
Other Non-Current Assets813.00M
Total Non-Current Assets2 B
Total Assets
14.29B

Financial Health Analysis

Current Ratio

1.23x

Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.

Debt-to-Equity Ratio

1.83x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

723 M

Positive working capital, but relatively tight. The company should monitor cash flow carefully.

Asset Composition

27% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Solventum Corporation Balance Sheet

SOLV โ€ข NYSE

Solventum Corporation Balance SheetDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
ASSETS
CURRENT ASSETS
878M
762M
194M
61M
91M
878M
762M
194M
61M
91M
1B
1.2B
1.3B
1.2B
1.2B
1B
1B
1.3B
1.2B
1.2B
0.0
185M
0.0
0.0
0.0
1.1B
965M
857M
873M
813M
881M
293M
155M
126M
108M
3.9B
3.2B
2.5B
2.2B
2.2B
NON-CURRENT ASSETS
1.3B
1.6B
1.5B
1.3B
1.3B
5.7B
6.4B
6.5B
6.4B
6.7B
2.6B
2.5B
2.9B
3.3B
3.7B
8.3B
8.9B
9.4B
9.7B
10.3B
813M
665M
530M
358M
253M
10.4B
11.2B
11.4B
11.4B
11.9B
14.3B
14.5B
13.9B
13.6B
14.1B
LIABILITIES
CURRENT LIABILITIES
687M
1B
583M
348M
320M
687M
618M
477M
348M
320M
0.0
394M
106M
0.0
0.0
0.0
260M
206M
168M
189M
0.0
200M
0.0
0.0
0.0
0.0
122M
106M
0.0
0.0
621M
572M
574M
559M
574M
1.8B
659M
365M
236M
323M
3.1B
2.7B
1.7B
1.3B
1.4B
NON-CURRENT LIABILITIES
5B
7.8B
8.3B
0.0
0.0
164M
225M
231M
215M
218M
910M
760M
-8B
326M
392M
6.1B
8.8B
549M
541M
610M
9.2B
11.5B
2.3B
1.9B
2B
SHAREHOLDERS' EQUITY
2M
2M
0.0
0.0
0.0
0.0
3.8B
0.0
0.0
0.0
1.8B
242M
0.0
0.0
0.0
-625M
-1.1B
-337M
-497M
-200M
3.9B
0.0
12B
12.2B
12.3B
5B
3B
11.7B
11.7B
12.1B
5B
3B
11.7B
11.7B
12.1B
SUMMARY
14.3B
14.5B
13.9B
13.6B
14.1B
5B
8B
8.3B
0.0
0.0
4.2B
7.2B
8.1B
-61M
-91M
173,444,597
173,444,597
173,444,597
173,444,597
173,444,597

SEC Filings

SOLV - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 27, 2026
May 21, 2026
2026
8-K

8-K 2026

N/A

May 20, 2026
May 15, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 05, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 05, 2026
May 05, 2026
2026
DEF 14A

DEF 14A 2025

N/A

March 27, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

March 24, 2026
March 20, 2026
2026
10-K

10-K 2025 FY

FY

February 27, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

February 26, 2026
February 26, 2026
2026
8-K

8-K 2025

N/A

December 16, 2025
December 16, 2025
2025
10-Q

10-Q 2025 Q3

Q3

November 06, 2025
September 30, 2025
2025
Showing 1 to 10 of 40 filings